Your browser doesn't support javascript.
loading
Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency.
Johnson, Matthew B; Ogishi, Masato; Domingo-Vila, Clara; De Franco, Elisa; Wakeling, Matthew N; Imane, Zineb; Resnick, Brittany; Williams, Evangelia; Galão, Rui Pedro; Caswell, Richard; Russ-Silsby, James; Seeleuthner, Yoann; Rinchai, Darawan; Fagniez, Iris; Benson, Basilin; Dufort, Matthew J; Speake, Cate; Smithmyer, Megan E; Hudson, Michelle; Dobbs, Rebecca; Quandt, Zoe; Hattersley, Andrew T; Zhang, Peng; Boisson-Dupuis, Stephanie; Anderson, Mark S; Casanova, Jean-Laurent; Tree, Timothy I; Oram, Richard A.
Afiliação
  • Johnson MB; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Ogishi M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY, USA.
  • Domingo-Vila C; Department of Immunobiology, School of Immunology and Microbial Sciences, Kings College London, London, UK.
  • De Franco E; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Wakeling MN; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Imane Z; Faculty of Medicine and Pharmacy, Mohammed 5 University of Rabat , Rabat, Morocco.
  • Resnick B; National Institute for Health and Care Research Exeter Clinical Research Facility, Royal Devon University Healthcare NHS Foundation Trust , Exeter, UK.
  • Williams E; Department of Immunobiology, School of Immunology and Microbial Sciences, Kings College London, London, UK.
  • Galão RP; Department of Infectious Diseases, School of Immunobiology and Microbial Sciences, Kings College London, London, UK.
  • Caswell R; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Russ-Silsby J; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Seeleuthner Y; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163 , Paris, France.
  • Rinchai D; Imagine Institute, Paris Cité University , Paris, France.
  • Fagniez I; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY, USA.
  • Benson B; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY, USA.
  • Dufort MJ; Center for Systems Immunology, Benaroya Research Institute , Seattle, WA, USA.
  • Speake C; Center for Systems Immunology, Benaroya Research Institute , Seattle, WA, USA.
  • Smithmyer ME; Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA, USA.
  • Hudson M; Center for Interventional Immunology, Benaroya Research Institute , Seattle, WA, USA.
  • Dobbs R; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Quandt Z; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Hattersley AT; National Institute for Health and Care Research Exeter Clinical Research Facility, Royal Devon University Healthcare NHS Foundation Trust , Exeter, UK.
  • Boisson-Dupuis S; Endocrine Division, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Anderson MS; Diabetes Center, University of California San Francisco , San Francisco, CA, USA.
  • Casanova JL; Clinical and Biomedical Sciences, Faculty of Health and Life Sciences, University of Exeter , Exeter, UK.
  • Tree TI; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY, USA.
  • Oram RA; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University , New York, NY, USA.
J Exp Med ; 221(6)2024 Jun 03.
Article em En | MEDLINE | ID: mdl-38634869
ABSTRACT
We previously reported two siblings with inherited PD-1 deficiency who died from autoimmune pneumonitis at 3 and 11 years of age after developing other autoimmune manifestations, including type 1 diabetes (T1D). We report here two siblings, aged 10 and 11 years, with neonatal-onset T1D (diagnosed at the ages of 1 day and 7 wk), who are homozygous for a splice-site variant of CD274 (encoding PD-L1). This variant results in the exclusive expression of an alternative, loss-of-function PD-L1 protein isoform in overexpression experiments and in the patients' primary leukocytes. Surprisingly, cytometric immunophenotyping and single-cell RNA sequencing analysis on blood leukocytes showed largely normal development and transcriptional profiles across lymphoid and myeloid subsets in the PD-L1-deficient siblings, contrasting with the extensive dysregulation of both lymphoid and myeloid leukocyte compartments in PD-1 deficiency. Our findings suggest that PD-1 and PD-L1 are essential for preventing early-onset T1D but that, unlike PD-1 deficiency, PD-L1 deficiency does not lead to fatal autoimmunity with extensive leukocytic dysregulation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antígeno B7-H1 Limite: Child / Child, preschool / Humans / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Antígeno B7-H1 Limite: Child / Child, preschool / Humans / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article